menu
    • menu

    Company profile for RenovoRx

    NEW Drugs in Dev: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology. RenovoRx has developed the RenovoCath, which is FDA cleared and ...
    RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology. RenovoRx has developed the RenovoCath, which is FDA cleared and now being investigated in an active clinical trial to prove extended median survival and improved quality of life.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RenovoRxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4546 El Camino Real Suite 223 Los Altos, CA 94022
    Telephone
    Telephone
    (650) 284-4433
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://renovorx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASCO GU

    ASCO GU

    Not Confirmed

    envelop Contact Supplier

    ASCO GU

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RenovoRx Establishes Renovocath Medical Advisory Board
    RenovoRx Establishes Renovocath Medical Advisory Board

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235315/0/en/RenovoRx-Establishes-RenovoCath-Medical-Advisory-Board.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Renovorx Names Mark Voll as CFO
    Renovorx Names Mark Voll as CFO

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232989/0/en/RenovoRx-Appoints-Experienced-Public-Company-Executive-Mark-Voll-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    RenovoRx Abstract Accepted for 2026 SIO Meeting
    RenovoRx Abstract Accepted for 2026 SIO Meeting

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227622/0/en/RenovoRx-Announces-Acceptance-of-Clinical-Data-Abstract-at-2026-Society-of-Interventional-Oncology-Annual-Scientific-Meeting.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    RenovoRx Expands RenoVoCath to Nine Cancer Centers
    RenovoRx Expands RenoVoCath to Nine Cancer Centers

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221723/0/en/RenovoRx-Expands-RenovoCath-Commercial-Adoption-to-Nine-Active-Cancer-Centers-Including-City-of-Hope-Cancer-Center-and-Moffitt-Cancer-Center.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    RenovoRx To Join Alphanorth Capital Event, Jan 16-18, 2026
    RenovoRx To Join Alphanorth Capital Event, Jan 16-18, 2026

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218616/0/en/RenovoRx-to-Participate-in-AlphaNorth-Capital-Event-January-16-18-2026.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    RenovoRx To Present New Clinical Data On TAMP Therapy At ASCO
    RenovoRx To Present New Clinical Data On TAMP Therapy At ASCO

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215383/0/en/RenovoRx-To-Announce-Promising-New-Clinical-Data-Using-its-TAMP-Therapy-Platform-in-an-Abstract-to-be-Presented-at-ASCO-GI-2026.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search